Dkh. Webb, PREVENTATIVE POLICIES IN TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN THE TREATMENT OF CANCER, Archives of Disease in Childhood, 71(6), 1994, pp. 532-533
Experience of transfusion associated graft versus host disease (TA-GvH
D) and current preventative policy in 22 UK children's cancer centres
was established by questionnaire. Cellular blood products were irradia
ted in all centres during bone marrow transplantation, but there was n
o consensus for children receiving standard chemotherapy. Irradiation
dose varied from 1500-5000 cGy and was below 2500 cGy in 12 units. Fiv
e cases of TA-GvHD were identified; all five children died.